Myopia is becoming increasingly common in young generations all over the world, and it is
predicted to become the most common cause of blindness and visual impairment in later life …

To evaluate the age-related efficacy and safety of atropine 0.01% eye drops over 2 years for
myopia control in a multicentric pediatric Spanish cohort. A non-controlled, interventional …

Over a century ago, atropine has been tested to arrest myopia progression with good results.
In recent years, many randomized clinical trials have tested different concentrations against …

Objective: To investigate the efficacy and safety of one-year treatment with 0.03% atropine
eye drops for slowing myopia progression among children aged 6–12 years. Methods …

Methods A systematic literature search of three databases was conducted. Interventions
were grouped into four categories: environmental/behavioral (outdoor time, near work) …

Purpose To estimate the effect of atropine eyedrops at different concentrations for myopia
control in children. Methods We conducted a Bayesian random-effects network meta …

Discussion: Atropine 1% drops have previously been associated with new or increased
seizure activity in a handful of case reports, however, it is our knowledge that this is the first …